Cargando…

Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study

BACKGROUND: Our objective was to clarify the characteristics and long-term survival of idiopathic pulmonary arterial hypertension (IPAH) patients with thyroid dysfunction and compare them with IPAH without thyroid dysfunction. METHODS: A retrospective analysis was conducted using prospectively colle...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yuling, Quan, Ruilin, Chen, Xiaoxi, Zhang, Gangcheng, Yang, Yuanhua, Chen, Yucheng, Yu, Zaixin, Gu, Qing, Xiong, Changming, Han, Huijun, He, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658611/
https://www.ncbi.nlm.nih.gov/pubmed/38020561
http://dx.doi.org/10.1183/23120541.00495-2023
_version_ 1785148228416569344
author Qian, Yuling
Quan, Ruilin
Chen, Xiaoxi
Zhang, Gangcheng
Yang, Yuanhua
Chen, Yucheng
Yu, Zaixin
Gu, Qing
Xiong, Changming
Han, Huijun
He, Jianguo
author_facet Qian, Yuling
Quan, Ruilin
Chen, Xiaoxi
Zhang, Gangcheng
Yang, Yuanhua
Chen, Yucheng
Yu, Zaixin
Gu, Qing
Xiong, Changming
Han, Huijun
He, Jianguo
author_sort Qian, Yuling
collection PubMed
description BACKGROUND: Our objective was to clarify the characteristics and long-term survival of idiopathic pulmonary arterial hypertension (IPAH) patients with thyroid dysfunction and compare them with IPAH without thyroid dysfunction. METHODS: A retrospective analysis was conducted using prospectively collected data. IPAH patients with thyroid dysfunction at baseline were included. Patients with other subgroups of PAH and Group 2–5 pulmonary hypertension were excluded. IPAH patients with euthyroid function were matched 1:1 to IPAH patients with thyroid dysfunction by age and sex. RESULTS: In total, 148 IPAH patients with thyroid dysfunction were included. Patients with hyperthyroidism, hypothyroidism, subclinical hyperthyroidism and subclinical hypothyroidism accounted for 16.2%, 18.9%, 8.1% and 56.8%, respectively. IPAH patients with hyperthyroidism showed the highest mixed venous oxygen saturation (S(vO(2))) and the lowest pulmonary vascular resistance (PVR) at baseline among subgroups, while patients with subclinical hypothyroidism had the lowest S(vO(2)) and highest PVR (p<0.05). Compared with IPAH without thyroid dysfunction, patients with hyperthyroidism (9.14 versus 13.86 WU; p<0.05) and hypothyroidism (10.70 versus 13.86 WU; p<0.05) showed significantly lower PVR. The haemodynamic profiles of patients with subclinical hypothyroidism were similar to IPAH with euthyroid function except for lower right atrial pressure (6 versus 8 mmHg; p=0.009). The long-term survival of patients with clinical thyroid dysfunction was better than IPAH without thyroid dysfunction, while that of those with subclinical diseases was comparable to the latter, even after adjusting for baseline haemodynamics and treatment. CONCLUSION: IPAH patients with clinical hyper- and hypothyroidism had better haemodynamics and survival than those without thyroid dysfunction, while patients with subclinical hypothyroidism had similar haemodynamics and survival profiles to the latter.
format Online
Article
Text
id pubmed-10658611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-106586112023-11-20 Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study Qian, Yuling Quan, Ruilin Chen, Xiaoxi Zhang, Gangcheng Yang, Yuanhua Chen, Yucheng Yu, Zaixin Gu, Qing Xiong, Changming Han, Huijun He, Jianguo ERJ Open Res Original Research Articles BACKGROUND: Our objective was to clarify the characteristics and long-term survival of idiopathic pulmonary arterial hypertension (IPAH) patients with thyroid dysfunction and compare them with IPAH without thyroid dysfunction. METHODS: A retrospective analysis was conducted using prospectively collected data. IPAH patients with thyroid dysfunction at baseline were included. Patients with other subgroups of PAH and Group 2–5 pulmonary hypertension were excluded. IPAH patients with euthyroid function were matched 1:1 to IPAH patients with thyroid dysfunction by age and sex. RESULTS: In total, 148 IPAH patients with thyroid dysfunction were included. Patients with hyperthyroidism, hypothyroidism, subclinical hyperthyroidism and subclinical hypothyroidism accounted for 16.2%, 18.9%, 8.1% and 56.8%, respectively. IPAH patients with hyperthyroidism showed the highest mixed venous oxygen saturation (S(vO(2))) and the lowest pulmonary vascular resistance (PVR) at baseline among subgroups, while patients with subclinical hypothyroidism had the lowest S(vO(2)) and highest PVR (p<0.05). Compared with IPAH without thyroid dysfunction, patients with hyperthyroidism (9.14 versus 13.86 WU; p<0.05) and hypothyroidism (10.70 versus 13.86 WU; p<0.05) showed significantly lower PVR. The haemodynamic profiles of patients with subclinical hypothyroidism were similar to IPAH with euthyroid function except for lower right atrial pressure (6 versus 8 mmHg; p=0.009). The long-term survival of patients with clinical thyroid dysfunction was better than IPAH without thyroid dysfunction, while that of those with subclinical diseases was comparable to the latter, even after adjusting for baseline haemodynamics and treatment. CONCLUSION: IPAH patients with clinical hyper- and hypothyroidism had better haemodynamics and survival than those without thyroid dysfunction, while patients with subclinical hypothyroidism had similar haemodynamics and survival profiles to the latter. European Respiratory Society 2023-11-20 /pmc/articles/PMC10658611/ /pubmed/38020561 http://dx.doi.org/10.1183/23120541.00495-2023 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
spellingShingle Original Research Articles
Qian, Yuling
Quan, Ruilin
Chen, Xiaoxi
Zhang, Gangcheng
Yang, Yuanhua
Chen, Yucheng
Yu, Zaixin
Gu, Qing
Xiong, Changming
Han, Huijun
He, Jianguo
Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title_full Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title_fullStr Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title_full_unstemmed Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title_short Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
title_sort clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658611/
https://www.ncbi.nlm.nih.gov/pubmed/38020561
http://dx.doi.org/10.1183/23120541.00495-2023
work_keys_str_mv AT qianyuling clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT quanruilin clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT chenxiaoxi clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT zhanggangcheng clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT yangyuanhua clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT chenyucheng clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT yuzaixin clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT guqing clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT xiongchangming clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT hanhuijun clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy
AT hejianguo clinicalfeaturesandlongtermsurvivalinidiopathicpulmonaryarterialhypertensionwiththyroiddysfunctioninsightsfromanationalmulticentreprospectivestudy